Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

103.73
Delayed Data
As of Mar 24
 +0.64 / +0.62%
Today’s Change
81.97
Today|||52-Week Range
108.01
+14.14%
Year-to-Date
FBT Regular Dividend: FBT began trading ex-dividend on 03/23/17. A $0.00 dividend will be paid to shareholders of record as of 03/27/17.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

Time to Buy Biotech ETFs?
Mar 13 / Zacks.com - Paid Partner Content
 

Performance

1 month+3.73% 3 years+10.18%
3 months+10.28% 5 years+20.98%
1 year+21.79% Since inception+16.67%
Data through 03/25/2017

Quote Details

Previous close$103.09
Open day’s range102.86 – 104.02
Net asset value (NAV)103.67 (03/24/2017)
Daily volume30,217
Average volume (3 months)76,833
Data as of 7:59pm ET, 03/24/2017

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+20.98%+16.84%
Expense Gross exp ratio0.55%1.33%
Risk 5 year sharpe ratio0.941.11
Net assets$902.3M$3.0B
Average market cap$9.0B$30.5B
Average P/E--22.3
Dividend / Share--0.32%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
KITE Kite Pharma Inc4.49%
ALNY Alnylam Pharmaceuticals Inc3.97%
MYGN Myriad Genetics Inc3.72%
RARE Ultragenyx Pharmaceutical Inc3.71%
ACAD ACADIA Pharmaceuticals Inc3.68%
JUNO Juno Therapeutics Inc3.67%
ICPT Intercept Pharmaceuticals Inc3.47%
AGIO Agios Pharmaceuticals Inc3.43%
AMGN Amgen3.42%
INCY Incyte Corp3.40%

Search for Jobs